This is the annual JAMA synthesis for the 2026-2027 respiratory season: 11,829 references screened, 155 eligible publications - 15 randomised trials, 84 comparative observational studies, 38 single-group safety studies and 18 burden studies - covering US-licensed COVID-19 vaccines.
The effectiveness figures are consistent with previous seasons and are worth carrying as numbers rather than impressions. Against hospitalisation, updated vaccines were 53.0% effective in adults 65 and over (95% CI 37.0-65.0) and 54.0% in adults 18-64 (1.0-78.0). Maternal vaccination was 58.0% effective against emergency or urgent care encounters in the vaccinated person (24.0-77.0) and 50-54% effective against COVID-related hospital contacts in their infants in the first two months of life, regardless of trimester. In children aged 9 months to 4 years, effectiveness against emergency visits was 76.0% (58.0-87.0). In immunocompromised adults, effectiveness against intensive care admission or death ranged 32.0-53.0%.
What this is not: a change in licensure, a new safety signal, or a recommendation. It is the evidence base that recommendations are built on, published so that the clinician being asked in clinic has something better than a recollection.
The adult intervals are worth noting before quoting them. The 18-64 estimate runs from 1.0% to 78.0% - technically significant, practically uninformative, and a good example of why the confidence interval belongs in the sentence. The most robust figures here are the maternal and paediatric ones. In India, where COVID-19 vaccination is not part of the routine seasonal programme, this evidence mainly informs advice to the immunocompromised and to pregnant patients who ask.
- Quote the interval with the estimate - 54% effectiveness with a floor of 1% is not a reassuring number
- Maternal vaccination protects the infant for the first two months regardless of trimester given
- Effectiveness in the immunocompromised is real but lower (32-53%) - layer other precautions
- This is a US-licensed-product review; Indian availability and CDSCO status are not addressed
- No new safety signal was identified across 38 dedicated product safety studies
The statistics, in plain English
Vaccine effectiveness of 53% means the vaccinated group had roughly half the hospitalisation rate of the unvaccinated - it does not mean half of vaccinated people are protected. Most of these estimates come from observational studies with comparator groups, where people who choose vaccination differ systematically from those who do not, and adjustment can only go so far. The 18-64 interval of 1.0% to 78.0% shows how few events underlie that particular estimate; treat any figure with an interval that wide as a direction rather than a number.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for top clinical updates, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free